相关实验视频
Updated: Jun 25, 2025

08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
10.4K
高血压中的天然尿素系统:目前对其调节的理解,向疗法和未来的挑战
Vishwadeep Shelke1, Neha Dagar1, Bhupendra Puri1
1Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan, 333031, India.
European journal of pharmacology
|May 25, 2024
概括
性尿素系统 (NPS) 为高血压提供了新的治疗点. 将针对NPS的疗法与氨酸- ангиотензин-阿尔多素系统 (RAAS) 调节剂相结合,显示出治疗心血管疾病和高血压的前景.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 性尿素系统 (NPS) 对于心脏内分泌功能至关重要,并且在治疗高血压等心血管疾病方面表现有前途.
- NPS与氨酸- ангиотензин- 阿尔多素系统 (RAAS) 之间的交叉导致了组合疗法,但它们对高血压病理生理学的影响需要进一步了解.
- 许多NPS的调节机制,特别是高血压,仍然未被探索,呈现潜在的治疗点.
研究的目的:
- 审查尿素系统 (NPS) 的表观遗传和其他调节剂作为高血压的潜在治疗标.
- 突出 NPS 向疗法的最新进展及其与 RAAS 调节器的结合.
- 为开发高血压有效治疗方法和解决心力衰竭流行病提供见解.
主要方法:
- 文献综述侧重于NPS的表观遗传和其他调节剂.
- 对NPS向疗法和RAAS调节器的临床前和临床数据的分析.
- 综合目前对高血压中NPS调节的理解.
主要成果:
- 表观遗传和其他NPS调节者代表了新型抗高血压疗法的有希望的目标.
- 涉及NPS调节剂 (例如M-心房) 和RAAS调节剂 (例如S086,sacubitril-aliskiren) 的组合疗法正在研究中.
- 了解NPS调节是开发高血压有效治疗的关键.
结论:
- 针对包括表观遗传因素在内的NPS调节体,为高血压治疗提供了一个新的途径.
- 与RAAS调节剂的联合疗法在治疗高血压和心血管疾病方面具有显著的潜力.
- 对NPS调节的进一步研究对于打击全球心力衰竭大流行至关重要.
相关概念视频
Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
618
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
618
Neural Regulation of Blood Pressure
2.8K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
2.8K

